← Evidence map

ReviewAustralian prescriber2024

Icosapent ethyl for reduction in cardiovascular disease risk in adults with hypertriglyceridaemia.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39777037